ReviewMedicine2025
Advancements in the clinical management of adhesive small bowel obstruction: A perspective.
Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Use of oral iohexol in patients with adhesive small intestinal obstruction.Turkish journal of surgery · 2026Article
- Clinical features of failure of conservative management in adult patients with adhesive small bowel obstruction: a retrospective cohort study.Frontiers in medicine · 2026Article
- Success rate and associated factors of conservative management of adhesive small bowel obstruction at Dessie comprehensive specialized hospital, Northeast Ethiopia.Scientific reports · 2025Article
- Clinical outcome of conservative versus surgical management in acute intestinal obstruction.Bioinformation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study rigorously addresses adhesive small bowel obstruction (ASBO), a common yet severe complication following abdominal surgery, marked by fibrous adhesions that disrupt normal intestinal operations. These adhesions often result in profound symptoms including severe abdominal pain and vomiting, and may lead to critical outcomes such as intestinal ischemia and necrosis. It delineates the considerable strain ASBO places on healthcare systems globally, highlighting its frequent occurrence post-surgery and the associated high medical costs and negative impacts on patient quality of life. The study explores recent advancements in the management of ASBO, focusing on innovative diagnostic techniques, surgical procedures, and therapeutic interventions designed to decrease recurrence rates and enhance patient recovery outcomes. Significant emphasis is placed on the effectiveness of a barrier agent shown to significantly decrease the necessity for surgical reinterventions by preventing the formation of new adhesions. The study proposes a modernized management strategy for ASBO, advocating for the adoption of the latest diagnostic and treatment approaches tailored to individual patient conditions. It recommends the integration of cutting-edge technologies and personalized treatment plans, aimed at boosting treatment efficacy and patient well-being, thereby mitigating the overall healthcare burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.